Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic

Abroad (travel likely)Recruiting

Conditions

Covid19 · Long COVID

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut de Recherches Cliniques de Montreal, Montreal, Quebec, Canada
Contact: Study coordinator (Charlotte Du Sablon, M.Sc.) · Charlotte.Dusablon@ircm.qc.ca · 514-987-5581
Contact: Principal Investigator (Emilia Liana Falcone, M.D., Ph.D.)

Study leads

Emilia Liana Falcone, M.D., Ph.D.
Principal Investigator
IRCM

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

Coronavirus · Respiratory Infection · COVID

Abroad (travel likely)Recruiting

Los Angeles, United States · Washington D.C., United States

COVID-19 in PID Survey

Primary Immune Deficiency · COVID

Abroad (travel likely)Recruiting

Paris, France

AGILE (Early Phase Platform Trial for COVID-19)

Covid19

Abroad (travel likely)RecruitingPHASE1, PHASE2

Cape Town, South Africa · Johannesburg, South Africa

Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Long Covid · Post-treatment Lyme Disease Syndrome · Chronic Fatigue Syndrome

Abroad (travel likely)RecruitingPHASE1, PHASE2

New York, United States